Vizuri Health Sciences LLC   Report issue

For profit Phase 4
Founded: Columbia MD United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2016
NCT03124407
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Vizuri Health Sciences LLC

Active Ingredients

Drugs in Phase 4 Trials (1)

capsaicin (qutenza) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1